Our findings demonstrate an association between KRAS mutations and specific clinicopathological features, such as tumour histological pattern, tumour grade, depth of invasion (pT), nodal involvement (pN), venous vascular invasion, and tumour bud number, which are important parameters for tumour progression and management. The gene discussed is KRAS; the disease is neoplasm.